MetabolicLab Use Only

Cagrilintide 5mg

Name: Cagrilintide 5mg
Brand: LooksMaxing Stack
SKU: cagrilintide-5mg
Availability: InStock

Long-acting amylin analog for appetite control and weight management.

Dosage

0.3–4.5 mg weekly subcutaneous

Half-life

~7 days

Purity

99%+

Form

Lyophilized powder

✅ 99%+ Purity📋 COA Included🚚 Fast US Shipping🔒 Secure Checkout

Buy Now Peptide Guides

What Is Cagrilintide 5mg?

Cagrilintide is a long-acting analog of amylin — the pancreatic satiety hormone. It acts centrally to suppress appetite, slows gastric emptying for prolonged satiety, and synergizes powerfully with GLP-1 agents (the CagriSema combination). The 5mg size supports shorter or initial-phase protocols.

Effectiveness Profile

Relative effectiveness scores derived from published preclinical literature across key endpoints.

Fat Loss88/100

Metabolic Health90/100

Insulin Sensitivity82/100

Appetite Control78/100

Scores are qualitative aggregates from animal and in vitro studies and are not a medical claim. For educational purposes only.

Applications & Benefits

Appetite suppression via amylin receptor

Slows gastric emptying for satiety

Synergistic with GLP-1 agents

Initial-dose CagriSema protocols

Effect Timeline

Expected milestones based on published preclinical data.

Days 1–7

Receptor Activation

Metabolic receptor engagement begins. Early appetite modulation and glucose sensitivity improvements detectable.

Week 2–4

Metabolic Shift

Progressive improvements in glucose and insulin dynamics. Meaningful weight and fat reduction begins.

Week 4–8

Significant Changes

Visceral fat reduction measurable. Lipid profiles and metabolic markers show improvement.

Week 8–16

Sustained Optimization

Continued metabolic improvement. Insulin sensitivity stabilizes at improved baseline; weight loss sustained.

Days 1–7

Receptor Activation

Metabolic receptor engagement begins. Early appetite modulation and glucose sensitivity improvements detectable.

Week 2–4

Metabolic Shift

Progressive improvements in glucose and insulin dynamics. Meaningful weight and fat reduction begins.

Week 4–8

Significant Changes

Visceral fat reduction measurable. Lipid profiles and metabolic markers show improvement.

Week 8–16

Sustained Optimization

Continued metabolic improvement. Insulin sensitivity stabilizes at improved baseline; weight loss sustained.

Timelines are derived from preclinical animal studies. Individual results in laboratory settings may vary. For educational purposes only.

Reconstitution Calculator

Calculate exact BAC water volume and dose measurements for Cagrilintide 5mg.

Step 1 — Vial Size (mg)

or custom:mg

Step 2 — Bacteriostatic Water to Add (mL)

Step 3 — Dose per Injection (mcg)

250 mcg

50 mcg2000 mcg

Results

2500

mcg / mL

Concentration

0.10 mL

per injection

Draw Volume

injections

Total Doses

For laboratory use only. This calculator is a reference tool — verify all calculations before use. Always use sterile technique with bacteriostatic water and sterile syringes.